Thursday, 15 October 2026

iberempresa

IBEX 3519.177,70▼ -0,28%EuroStoxx 506168,26▼ -0,36%S&P 5007725,66▲ +0,09%€/$1,1204▲ +0,42%Brent106,07▲ +0,01%Bitcoin73.625▲ +1,04%
Breaking

Lytenava

Latest Lytenava news

1 article

Primer plano de un frasco de colirio oftalmológico con un calendario borroso al fondo

Outlook Therapeutics: FDA to Decide on Eye Drug Lytenava on July 29

Outlook Therapeutics faces a pivotal July: shareholders vote on capital increase on the 16th and FDA decides on Lytenava on the 29th.